TOP About TaihoFinancial Highlights

Financial Highlights

Taiho Pharmaceutical Co.,Ltd. and Subsidiaries Fiscal years 2010,2009,2008,2007 and 2006

Millions of yen						Thousands of U.S. dollars(Note)
Years ended	2010	2009	2008	2007	2006	2010
Years ended	Mar. 31, 2011	Mar. 31, 2010	Mar. 31, 2009	Mar. 31, 2008	Mar. 31, 2007	Mar. 31, 2011
For the Year:
Net sales	¥123,581	¥120,716	¥91,027	¥128,478	¥131,739	$1,488,934
Operating income	15,778	14,564	11,589	23,072	28,831	190,100
Net income	12,127	10,464	8,067	15,183	24,074	146,120
Research and development expenses	30,262	29,735	22,439	27,911	27,424	228,973
Percentage of net sales(%)	24.5%	24.6%	24.7%	21.7%	20.8%	24.7%
Capital expenditures	5,840	4,396	1,469	4,133	5,600	14,998
At Year-End:
Total assets	¥354,882	¥346,619	¥334,290	¥331,054	¥326,254	$4,275,694
Total shareholders'equity	319,333	313,019	306,271	299,895	285,875	3,847,389
Employees	2,622	2,643	2,513	2,589	2,468	2,622

Note : U.S. dollar amounts are translated from yen, for convenience only, at the rate of ¥83=US$1, the approximate exchange rate at March 31,2011.